ADT Pharmaceuticals, LLC SBIR Phase I Award, September 2017
A SBIR Phase I contract was awarded to ADT Pharmaceuticals, LLC in September, 2017 for $302,000.0 USD from the U.S. Department of Health & Human Services.
All edits
Edits on 26 Jun, 2023
Golden AI
Infobox
Government Agency
0
Award Amount (USD)
302,0000
Date Awarded
September 21, 2017
0End Date
March 21, 2019
0SBIR/STTR Award Recipient
Contract Number (US Government)
1R43CA217502-01A10
Award Phase
Phase I0
Award Type
SBIR0
Edits on 8 May, 2021
Golden AI
Edits made to:
Infobox (+1/-1 properties)
Infobox
Edits on 12 Mar, 2021
Golden AI
Edits made to:
Infobox (+10 properties)
ADT Pharmaceuticals, LLC SBIR Phase I Award, September 2017
Infobox
Is a
Recipient
Award Type
SBIR
Award Identifier
1R43CA217502-01A1
Phase
Phase I
Amount (USD)
302,000
Date Awarded
September 21, 2017
End Date
March 21, 2019
Find more entities like ADT Pharmaceuticals, LLC SBIR Phase I Award, September 2017
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
